As a result, glutamine metabolism of BRAF-mutant thyroid cancer cells is reprogrammed due to down-regulation of c-Myc downstream glutamine transporter and glutaminases, thereby making these cells more sensitive to glutamine deprivation and glutaminase inhibitor. This evidence concerns the gene GLS and thyroid cancer.